ALEXANDRIA REAL ESTATE EQ IN's ticker is ARE and the CUSIP is 015271109. A total of 11 filers reported holding ALEXANDRIA REAL ESTATE EQ IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Leibman Financial Services, Inc. | 20,486 | $2,597,010 | 2.16% |
| Pensionfund DSM Netherlands | 21,700 | $2,751 | 1.66% |
| Green Alpha Advisors, LLC | 16,223 | $2,056,616 | 1.48% |
| Pensionfund Sabic | 8,450 | $1,071 | 0.34% |
| Harbour Capital Advisors, LLC | 3,554 | $445,494 | 0.12% |
| Czech National Bank | 27,392 | $3,472,484 | 0.05% |
| DnB Asset Management AS | 28,262 | $3,582,774 | 0.02% |
| FULTON BANK, N.A. | 1,991 | $252,399 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 1,839 | $233,130 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 2,078 | $263,428 | 0.01% |
| Versant Capital Management, Inc | 26 | $3,296 | 0.00% |
About ALEXANDRIA REAL ESTATE EQ IN
Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) that specializes in the ownership, operation, and development of life science and technology properties. The company is headquartered in Pasadena, California, and has a portfolio of over 33 million square feet of rentable space across key innovation clusters in the United States, Canada, and the United Kingdom.
ARE's focus on life science and technology properties has proven to be a wise investment strategy, as the demand for these types of properties has increased in recent years. The company's properties are home to some of the world's leading pharmaceutical, biotechnology, and technology companies, making it a key player in the industry.
In addition to its impressive portfolio, ARE has a strong financial position, with a market capitalization of over $30 billion and a debt-to-equity ratio of just 0.67. The company has also consistently delivered strong financial results, with a 5-year average revenue growth rate of 16.5% and a 5-year average return on equity of 6.9%.
ARE's leadership team is also impressive, with Joel Marcus serving as the company's Executive Chairman and Peter Moglia as its Chief Financial Officer. Both Marcus and Moglia have extensive experience in the real estate industry and have been instrumental in the company's success.
Overall, Alexandria Real Estate Equities, Inc. is a strong player in the life science and technology real estate market, with a solid portfolio, strong financials, and experienced leadership team. Investors looking for exposure to this growing industry may want to consider adding ARE to their portfolios.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists ALEXANDRIA REAL ESTATE EQ IN's shareholders in Q4 2023. To view ALEXANDRIA REAL ESTATE EQ IN's shareholder history, click here.